Online Store

2017 AAPB Webinar 11: Evidence for the Effectiveness of Biofeedback in Cardiovascular Disease

2017 AAPB Webinar 11: Evidence for the Effectiveness of Biofeedback in Cardiovascular Disease
Category: Recordings (video & audio)

Presented by Christine Moravec, PhD, Cleveland Clinic

No CEU's available for this recording.

Price: $65.00
Available for download after purchase



Course Description:
The session will first review the physiology of the cardiovascular system, including regulation by the autonomic nervous system. The pathophysiology of cardiovascular disease will be presented, with an emphasis on autonomic dysfunction and its consequences. Reversibility of the changes in autonomic function which occur in cardiovascular diseases will be explored. Finally, evidence for the effectiveness of biofeedback in patients with cardiovascular disease will be reviewed, including evidence from the literature and from Dr. Moravec's work. The need for future studies and their potential design will be addressed.

Learning Objectives:
Professionals who complete this webinar will:

  • Explain the role of the autonomic nervous system in cardiovascular regulation.
  • Discuss the progression of cardiovascular disease and why autonomic nervous system dysfunction plays an important role in symptoms and progression.
  • Review evidence that biofeedback can have an effect on symptom management and disease progression in patients with cardiovascular disease.
  • Understand the need for future studies of biofeedback in cardiovascular disease and discuss important considerations for those studies.

Level: Intermediate

Prerequisites: None. Advance preparation is not required.

Presenter Bio:
Christine Moravec, PhD

Christine S Moravec PhD is a research scientist whose work focuses on the role of the autonomic nervous system in chronic disease progression and treatment. Much of Dr. Moravec's work has centered on cardiovascular disease. With training in physiology, Dr. Moravec has studied the basic cellular and molecular characteristics of the diseased human heart, and has also tested the hypothesis that various interventions, including medical, surgical and psychophysiological treatments can cause reversal of these biologic changes. Together with Dr. Michael McKee, she has studied the effects of biofeedback in patients with coronary artery disease, lung cancer and multiple sclerosis. As a physiologist, Dr. Moravec is interested in direct effects of biofeedback on autonomic nervous system regulation and how that regulation can have a role in disease prevention and regression.






Follow AAPBiofeedback on Twitter
Follow 121999491198448 on Facebook
image widget